Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have discovered a new way to manufacture human red blood cells (RBCs) that cuts the culture time by half compared to existing methods and uses novel sorting and purification methods that are faster, more precise, and less costly. Blood transfusions save millions of lives every year, but over half the world’s countries do not have sufficient blood supply to meet their needs. The ability to manufacture RBCs on demand, especially the universal donor blood (type O+),…
